Display options
Share it on

Evid Based Complement Alternat Med. 2016;2016:2601830. doi: 10.1155/2016/2601830. Epub 2016 Feb 25.

Effect of Kuijie Granule on the Expression of TGF-β/Smads Signaling Pathway in Patients with Ulcerative Colitis.

Evidence-based complementary and alternative medicine : eCAM

Xinjie Xu, Chunhua Xu, Shakir M Saud, Xiaoming Lu, Lei Liu, Li Fang, Xiaowei Zhang, Jiangong Hu, Weidong Li

Affiliations

  1. Traditional Chinese Medicine Department, Affiliated Hospital of Taishan Medical University, Shandong 271000, China.
  2. Gastroenterology Department, Chengdu Second People's Hospital, Sichuan 610017, China.
  3. Department of Cell Biology and Molecular Medicine, Rutgers New Jersey Medical School, Newark, NJ 07103, USA.
  4. Gastroenterology Department, Liaocheng Second People's Hospital, Shandong 252600, China.
  5. Pathology Department, Affiliated Hospital of Taishan Medical University, Shandong 271000, China.
  6. Dermatology Department, Tai'an Maternal and Child Health-Care Hospital, Shandong 271000, China.
  7. Gastroenterology Department, Affiliated Hospital of Taishan Medical University, Shandong 271000, China.
  8. Department of Infectious Diseases, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China.

PMID: 27019660 PMCID: PMC4785256 DOI: 10.1155/2016/2601830

Abstract

The dysregulation of TGF-β/Smads signaling pathway has been postulated to contribute to the development of ulcerative colitis (UC) and the manifestation of clinical symptoms. Kuijie Granule is a prescription medicine used clinically in China to alleviate the symptoms associated with UC. To evaluate whether the clinical benefit of Kuijie Granule is associated with TGF-β/Smads signaling, we measured the expression levels of TGF-β/Smads signaling proteins (TGF-β1, TGF-βRII, Smad2, Smad4, Smad6, and Smad7) in the intestinal mucosa of 72 patients with UC treated with Kuijie Granule for 60 days. Colonic tissues were obtained by a virtual colonoscopy guided biopsy before and after Kuijie Granule treatment followed by pathological analysis and quantitative analysis of TGF-β/Smads using immunohistochemistry. Kuijie Granule treatment significantly improved symptoms associated with UC, which include diarrhea, mucus production, pus and blood in stool, abdominal pain and distention, and tenesmus. The clinical benefit of Kuijie Granule treatment correlated with decreased expression of TGF-β1 and Smad7 and increased expression of TGF-βRII and Smad4. These clinical results indicate that Kuijie Granule can alleviate the symptoms associated with UC and modulate TGF-β/Smads signaling.

References

  1. Eur J Biochem. 2000 Dec;267(24):6954-67 - PubMed
  2. Gastroenterology. 2007 Apr;132(4):1410-9 - PubMed
  3. Am J Gastroenterol. 2000 May;95(5):1263-76 - PubMed
  4. J Cell Sci. 2000 Apr;113 ( Pt 7):1101-9 - PubMed
  5. Cell. 2003 Jun 13;113(6):685-700 - PubMed
  6. Br J Cancer. 2008 May 20;98 (10 ):1670-4 - PubMed
  7. Arch Dis Child. 2003 Nov;88(11):995-1000 - PubMed
  8. Cell Death Dis. 2013 Mar 14;4:e541 - PubMed
  9. Cell Tissue Res. 2012 Jan;347(1):21-36 - PubMed
  10. J Gastroenterol. 2009;44(4):249-60 - PubMed
  11. Gastroenterology. 2004 May;126(6):1504-17 - PubMed
  12. Curr Opin Cell Biol. 2000 Apr;12(2):235-43 - PubMed
  13. FEBS Lett. 2012 Jul 4;586(14 ):1897-905 - PubMed
  14. Am J Gastroenterol. 2011 Apr;106 Suppl 1:S2-25; quiz S26 - PubMed
  15. Curr Drug Targets. 2013 Nov;14(12):1400-4 - PubMed
  16. Contrib Nephrol. 2011;170:75-82 - PubMed
  17. Gastroenterology. 2011 Apr;140(4):1155-65 - PubMed
  18. World J Gastroenterol. 2002 Feb;8(1):158-61 - PubMed
  19. J Leukoc Biol. 2009 Jan;85(1):29-33 - PubMed
  20. Cell Res. 2009 Jan;19(1):36-46 - PubMed
  21. Cell Res. 2009 Jan;19(1):71-88 - PubMed

Publication Types